{
    "Trade/Device Name(s)": [
        "BIO-VENTURE Rapid Amphetamine Test Cassette for OTC Use",
        "BIO-VENTURE Rapid Oxazepam Test Cassette for OTC Use",
        "BIO-VENTURE Rapid Cocaine Test Cassette for OTC Use",
        "BIO-VENTURE Rapid Methamphetamine Test Cassette for OTC Use",
        "BIO-VENTURE Rapid Morphine Test Cassette for OTC Use",
        "BIO-VENTURE Rapid Marijuana Test Cassette for OTC Use",
        "BIO-VENTURE Rapid Amphetamine Test Cassette for Rx Use",
        "BIO-VENTURE Rapid Oxazepam Test Cassette for Rx Use",
        "BIO-VENTURE Rapid Cocaine Test Cassette for Rx Use",
        "BIO-VENTURE Rapid Methamphetamine Test Cassette for Rx Use",
        "BIO-VENTURE Rapid Morphine Test Cassette for Rx Use",
        "BIO-VENTURE Rapid Marijuana Test Cassette for Rx Use"
    ],
    "Submitter Information": "Shanghai Venture Bio-Tech CO., Ltd.",
    "510(k) Number": "K180878",
    "Predicate Device Reference 510(k) Number(s)": [
        "K173303"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJC",
        "LDJ",
        "DKZ",
        "JXM",
        "NFT",
        "DIO",
        "NFY",
        "NFV",
        "NGG",
        "DNK",
        "NGI",
        "NFW"
    ],
    "Summary Letter Date": "October 30, 2018",
    "Summary Letter Received Date": "November 5, 2018",
    "Submission Date": "December 15, 2018",
    "Regulation Number(s)": [
        "21 CFR 862.3100",
        "21 CFR 862.3170",
        "21 CFR 862.3250",
        "21 CFR 862.3610",
        "21 CFR 862.3870",
        "21 CFR 862.3640"
    ],
    "Regulation Name(s)": [
        "Amphetamine Test System",
        "Benzodiazepine Test System",
        "Cocaine and Cocaine Metabolite Test System",
        "Methamphetamine Test System",
        "Cannabinoid Test System",
        "Morphine Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "d-Amphetamine",
        "Oxazepam",
        "Benzoylecgonine",
        "d-Methamphetamine",
        "Morphine",
        "Delta-9-THC-COOH"
    ],
    "Specimen Type(s)": [
        "Human Urine"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        ""
    ],
    "Method(s)/Technology(ies)": [
        "Lateral flow immunoassay",
        "Immunochromatographic assay"
    ],
    "Methodologies": [
        "Competitive binding immunochromatography",
        "Qualitative immunoassay"
    ],
    "Submission Type(s)": [
        "Cassette"
    ],
    "Document Summary": "FDA 510(k) summary for BIO-VENTURE Rapid Drug Test Cassettes for OTC and Rx use for qualitative urine detection of amphetamine, oxazepam, cocaine, methamphetamine, morphine, and marijuana",
    "Indications for Use Summary": "Rapid lateral flow immunoassay for qualitative detection of d-Amphetamine, Oxazepam, Benzoylecgonine, d-Methamphetamine, Morphine and Delta-9-THC-COOH in human urine for preliminary screening; intended for over-the-counter and prescription use",
    "fda_folder": "Toxicology"
}